Zentalis Pharmaceuticals Llc (ZNTL) — Working Capital to Net Assets Ratio
Zentalis Pharmaceuticals Llc (ZNTL) has a Working Capital to Net Assets ratio of 100.2% as of December 2025. Working capital of $216.63 Million (current assets of $253.19 Million minus current liabilities of $36.56 Million) is measured against net assets of $216.20 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See ZNTL defensive interval ratio to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Zentalis Pharmaceuticals Llc Working Capital to Net Assets (2018–2025)
This chart shows how Zentalis Pharmaceuticals Llc's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2018 to 2025. As of December 2025, the ratio stands at 100.2%, reflecting working capital of $216.63 Million against net assets of $216.20 Million USD. For the complete balance sheet picture, see ZNTL asset base.
Annual Working Capital to Net Assets for Zentalis Pharmaceuticals Llc (2018–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Zentalis Pharmaceuticals Llc from 2018 to 2025, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Zentalis Pharmaceuticals Llc liquidity resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 100.2% | $216.63 Million | $216.20 Million | $253.19 Million | $36.56 Million | ▲ +1.3 pp |
| 2024 | 98.9% | $333.34 Million | $337.19 Million | $386.07 Million | $52.73 Million | ▲ +1.2 pp |
| 2023 | 97.7% | $427.35 Million | $437.39 Million | $496.72 Million | $69.37 Million | ▲ +6.6 pp |
| 2022 | 91.1% | $395.29 Million | $434.02 Million | $451.93 Million | $56.65 Million | ▲ +6.9 pp |
| 2021 | 84.2% | $306.83 Million | $364.48 Million | $350.77 Million | $43.94 Million | ▼ -10.8 pp |
| 2020 | 94.9% | $316.50 Million | $333.38 Million | $345.10 Million | $28.60 Million | ▲ +16.0 pp |
| 2019 | 78.9% | $53.99 Million | $68.42 Million | $68.89 Million | $14.90 Million | ▲ +15.6 pp |
| 2018 | 63.4% | $20.47 Million | $32.31 Million | $26.68 Million | $6.21 Million | — |